2012 San Antonio Breast Cancer Symposium
Guest blog from Andrea Rader, Susan G. Komen for the Cure Managing Director, Communications
One of the biggest breast cancer conferences of the year gets underway tomorrow (Dec. 4) in San Antonio, Texas. The San Antonio Breast Cancer Symposium, hosted by the American Association of Cancer Researchers (AACR) — and strongly supported by Susan G. Komen for the Cure — brings together thousands of researchers, clinicians and advocates from around the world to report on the latest in trends in breast cancer research and treatment.
We look forward to this every year, because it’s an opportunity to see the progress being made in research that we’ve funded (Susan G. Komen is the largest nonprofit funder of breast cancer research — $750 million in our 30 years), and trends in treatment and care.
We’re also pleased to see some of the outstanding leaders in breast cancer research receiving honors for their contributions to breast cancer science and care.
The recognition begins today — Convention Eve — when AACR presents its Outstanding Investigator Award to Kornelia Polyak, M.D., Ph.D., of Dana Farber Cancer Institute. The Outstanding Investigator Award is supported by a $10,000 grant from Komen to recognize investigators 50 or under whose work has had or may have a far-reaching impact on breast cancer. Dr. Polyak will present a 25-minute lecture, entitled Breast Tumor Evolution: Drivers and Clinical Relevance on Thursday. Dec. 6. Read more about Dr. Polyak.
On Wednesday, we will celebrate the 20th Anniversary of our Brinker Awards for Scientific Distinction in Basic Science and Clinical Research, with honors to an American clinician-scientist and an Israeli researcher.
This year’s award for Clinic Research will be presented to Hyman B. Muss, M.D., Professor of Medicine and the Director of the Geriatric Oncology Program at University of North Carolina Lineberger Comprehensive Cancer Center in Chapel Hill. Dr. Muss has been leading research and clinical care for older breast cancer patients for more than 30 years.
Yosef Yarden, Ph.D., of the Harold and Zelda Goldenberg Professor of Molecular Cell Biology at the Weizmann Institute of Science in Rehovot, Israel, will be honored with the Brinker Award for Basic Science. Prof. Yarden has been instrumental in advancing our understanding of the biology of growth factors and their receptors, and their role in human cancers. His research has been crucial to establishing growth factor receptors as prime targets for cancer drugs.
Both will present findings at the San Antonio Breast Cancer Symposium Wednesday, Dec., 6, and honored at a reception that evening. Later this week, Dr. Muss and Prof. Yarden will share personal observations about their week in our Voices of Impact program.
Komen scientific staff, Komen Scholars, Advocates in Science and our Scientific Advisory Board will be out in force at the Symposium, and we’ll report on novel and interesting findings from the Symposium in this space during the week. Or follow the conversation using the conference hashtags #SABCS and #SABCS12 on Twitter!
About the author
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen and launched the global breast cancer movement. Today, Komen is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the Cure®, we have invested more than $1.9 billion to fulfill our promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world.